Abstract
Chronic infections ofTrypanosoma brucei GVR 35/2 in mice, normally relapse after conventional chemotherapy because infective trypanosomes in the brain escape the action of the drug and are able to multiply and eventually re-establish a parasitaemia. However, if treatment consists of a single dose of 1×20 mg/kg suramin followed 3 or 4 days later by a 2-substituted 5-nitroimidazole, given intraperitoneally, either as a single dose or as a course of daily injections, relapses rarely occur and the majority of the mice are permanently cured. The minimum effective levels for the three 5-nitroimidazole compounds (Merck Sharp and Dohme, Rahway, NJ, USA) were two doses of 10 mg/kg of L611,744; four doses of 10 mg/kg of MK 436; and three doses of 10 mg/kg of L634,549. Generally it was more effective to divide a given total dose into two or more daily doses, rather than to give the 5-nitroimidazole as a single treatment. The effective dose levels are low enough to be of practical significance and, if the 5-nitroimidazoles were ever licensed for humans, might well prove to be an alternative to melarsoprol treatment for the elimination of trypanosomes from the central nervous system.
Similar content being viewed by others
References
Apted FIC (1980) Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the eastern hemisphere. Pharmacol Ther 11: 391–413
Jennings FW, Gray GD (1983) Relapsed parasitaemia following chemotherapy of chronicT. brucei infections in mice and its relation to cerebral trypanosomiasis. Contrib Microbiol Immunol 7: 147–154
Jennings FW, Urquhart GM (1983) The use of the 2-substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronicT. brucei infections in mice. Z Parasitenkd 69: 577–581
Jennings FW, Whitelaw DD, Urquhart GM (1977) The relationship between duration of infections withTrypanosoma brucei in mice and efficacy of chemotherapy. Parasitology 75: 143–153
Jennings FW, Whitelaw DD, Holmes PH, Chizyuka HGB, Urquhart GM (1979) The brain as a source of relapsingTrypanosoma brucei infection in mice after chemotherapy. Int J Parasitol 9: 381–384
Jennings FW, Urquhart GM, Murray PK, Miller BM (1980) “Berenil” and nitroimidazole combinations in the treatment ofTrypanosoma brucei infection with central nervous system involvement. Int J Parasitol 10: 27–32
Jennings FW, Urquhart GM, Murray PK, Miller BM (1983) Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murineTrypanosoma brucei infections with nervous system involvement. Trans R Soc Trop Med Hyg 77: 693–698
Murray PK, Jennings FW (1983) African trypanosomiasis: Chemotherapy in rodent models of sleeping sickness. In: Keusch, Waldström (eds) Animal models for experimental bacterial and parasitic infections. Elsevier/North Holland, Amsterdam, pp 343–354
Raether W, Seidenath H (1983) The activity of fexinidazole (Hoe 239) against experimental infections withTrypanosoma cruzi, trichomonads andEntamoeba histolytica. Ann Trop Med Parasitol 77: 13–26
Richle RW, Raaflaub J (1980) Differences of effective antitrypanosomal dosages of benznidazole in mice and man: chemotherapeutic and pharmokinetic results. Acta Trop 37: 257–261
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jennings, F.W., Urquhart, G.M., Murray, P.K. et al. The use of 2-substituted 5-nitroimidazoles in the treatment of chronic murineTrypanosoma brucei infections with central nervous system involvement. Z. Parasitenkd. 70, 691–697 (1984). https://doi.org/10.1007/BF00927120
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00927120